Clinical ResearchCoronaryA Registry-Based Randomized Trial Comparing Radial and Femoral Approaches in Women Undergoing Percutaneous Coronary Intervention: The SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) Trial
Key Words
Abbreviations and Acronyms
Cited by (0)
Abbott Vascular, Medtronic Vascular (grant no. A 1054367), Terumo Medical, The Medicines Company, Daiichi Sankyo/Eli Lilly and Company (grant no. H7T-US-X014), ACIST Medical, Guerbet, FDA Office of Women’s Health (grant no. HHSF223201111381P), and The Duke Clinical Research Institute funded this study. None of the funding sources had a role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation or approval of the manuscript; and decision to submit the manuscript for publication. Some funding sources reviewed the manuscript before submission. Dr. Rao is a consultant for The Medicines Company and Terumo Medical. Dr. Jolly has received research funding from Medtronic. Dr. Waksman has received consulting fees and honoraria from Biotronik, Medtronic, Boston Scientific, Abbott Vascular, and AstraZeneca; is on Speakers' Bureau of AstraZeneca; and is a shareholder in Endothelix, Inc. Dr. Mehran has received research grant support from The Medicines Company, Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly & Co./Daiichi Sankyo, Regado Biosciences, and STENTYS and consulting fees from Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, CSL Behring, Janssen (JNJ), Maya Medical, and Merck and is on the Advisory Board of Covidien, Janssen Pharmaceuticals, and Sanofi-Aventis. Dr. Harrington has received research grants from Merck, The Medicines Company, Sanofi-Aventis, Bristol-Myers Squibb, and Portola Pharma and consulting fees from Merck, Bristol-Myers Squibb, AstraZeneca, Gilead, Jansen/J&J, Merck, WebMD, CSL Behring, MyoKardia, The Medicines Company, and Amgen. Dr. Krucoff has received consulting fees and research support from Medtronic, Abbott Vascular, Terumo, and Acist. Dr. Anstrom has received research support from AstraZeneca, Lilly, Medtronic and consulting fees from Abbott Vascular, AstraZeneca, BMS, Pfizer, GSK, and Ikaria. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.